NCT02392325View on ClinicalTrials.gov

Evaluating the Clinical and Immune Response to Two Dengue Virus Vaccines in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

February 28, 2017

Conditions
Dengue
Interventions
BIOLOGICAL

rDEN1Δ30

Administered subcutaneously in 0.5 mL containing 10\^3.0 plaque-forming units (PFU)

BIOLOGICAL

Placebo

Administered subcutaneously in 0.5 mL

BIOLOGICAL

rDEN2Δ30-7169

Administered subcutaneously in 0.5 mL containing 10\^3.0 PFU

Trial Locations (1)

21205

Center for Immunization Research, Johns Hopkins School of Public Health, Baltimore

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT02392325 - Evaluating the Clinical and Immune Response to Two Dengue Virus Vaccines in Healthy Adults | Biotech Hunter | Biotech Hunter